ResearcherNo recent work listed

Gülcan Bulut

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-7382-0972; OpenAlex author ID A5006368444. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper

Papers 2

Metastatic Pancreatic Cancer Second-Line Treatment Options: Is the Difference Only in Cost? Co-author DOI 10.1007/s12029-020-00573-y ↗
Pancreatic Cancer Patients Who Cannot Undergo Curative Surgery Live As Much As Patients Over 70 Years Old Last author DOI 10.21203/rs.3.rs-150867/v1 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Serkan Yıldırım · 2 shared papers, 2021–2022 · strength 0.32
- Paper Metastatic Pancreatic Cancer Second-Line Treatment Options: Is the Difference Only in Cost? DOI 10.1007/s12029-020-00573-y ↗
- Paper Pancreatic Cancer Patients Who Cannot Undergo Curative Surgery Live As Much As Patients Over 70 Years Old DOI 10.21203/rs.3.rs-150867/v1 ↗
Ferhat Ekinci · 2 shared papers, 2021–2022 · strength 0.32
- Paper Metastatic Pancreatic Cancer Second-Line Treatment Options: Is the Difference Only in Cost? DOI 10.1007/s12029-020-00573-y ↗
- Paper Pancreatic Cancer Patients Who Cannot Undergo Curative Surgery Live As Much As Patients Over 70 Years Old DOI 10.21203/rs.3.rs-150867/v1 ↗
Atike Pınar Erdoğan · 2 shared papers, 2021–2022 · strength 0.32
- Paper Metastatic Pancreatic Cancer Second-Line Treatment Options: Is the Difference Only in Cost? DOI 10.1007/s12029-020-00573-y ↗
- Paper Pancreatic Cancer Patients Who Cannot Undergo Curative Surgery Live As Much As Patients Over 70 Years Old DOI 10.21203/rs.3.rs-150867/v1 ↗
Elvina Almuradova · 1 shared paper, 2022 · strength 0.16
- Paper Metastatic Pancreatic Cancer Second-Line Treatment Options: Is the Difference Only in Cost? DOI 10.1007/s12029-020-00573-y ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.